Effect of prothrombin Belgrade mutation, causing antithrombin resistance, on fibrin clot properties

• Published in: International journal of laboratory hematology Vol. 46; no. 2; pp. 329 - 335
• Main Authors: Dunjic Manevski, Sofija, Cumbo, Marija, Pruner, Iva, Gvozdenov, Maja, Tomic, Branko, Taxiarchis, Apostolos, Antovic, Jovan, Djordjevic, Valentina
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.04.2024
• Subjects: Anticoagulants - pharmacology; Antithrombin; Antithrombin III - genetics; Antithrombins; Confocal microscopy; Electron microscopy; Fibrin; Fibrin - chemistry; Fibrinogen; Fibrinolysis; HEK293 Cells; Hemostasis; Humans; Lysis; Medicin och hälsovetenskap; Microscopy; Mutation; Plasma; Prothrombin; Prothrombin - genetics; Prothrombin - metabolism; Prothrombin gene; Sodium; Sodium - pharmacology; Thrombin; Thrombin - metabolism; thrombosis; Thrombosis - genetics; Transfection; Turbidity; mutation; microscopy; thrombosis; fibrin; prothrombin
• ISSN: 1751-5521; 1751-553X; 1751-553X
• DOI: 10.1111/ijlh.14195

Introduction Prothrombin Belgrade mutation is the result of the c.1787G>A substitution in the prothrombin gene. It is located in the antithrombin and sodium binding site and leads to impaired inactivation of thrombin by antithrombin, resulting in antithrombin resistance and thrombotic disorders. However, it negatively affects sodium binding and may have hypocoagulant effects. Considering that prothrombin Belgrade mutation mechanism is still not fully elucidated and that sodium binding is important for thrombin affinity towards fibrinogen, our aim was to determine whether this mutation affects fibrin clot formation and lysis. Methods Using HEK293T cell line, recombinant wild type and mutated prothrombin were generated by transient transfection. Samples that correspond to plasma of a non‐carrier, heterozygous and homozygous carriers were reconstituted using prothrombin deficient plasma and recombinant proteins. Reconstituted samples were used in OHP assay (Overall Hemostasis Potential) to determine kinetic profiles of coagulation and fibrinolysis. Clot turbidity assay was performed to observe kinetics of clot formation and lysis more closely. Fibrin clots formed in reconstituted plasma samples were analyzed by confocal microscopy to determine density of fibrin network. Fibrin clots were additionally observed using electron microscopy to determine thickness of individual fibrin fibers. Results No significant difference found in OHP, OCP, OFP, and fibrin network density between wild type, heterozygous, and homozygous carrier reconstituted plasma samples. There were significant differences between samples for slope and slope time parameters in kinetic profiles and fibrin fiber thickness. Conclusions Results indicate that prothrombin Belgrade mutation has no significant impact on fibrinolysis, however it may affect kinetics of clot formation and its architecture.